Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg L Beilhartz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Viruses|October 14, 2011
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and InhibitorsGreg L Beilhartz, Matthias Götte
Trends in Microbiology|November 9, 2015
Small Molecules Take A Big Step Against Clostridium difficileGreg L Beilhartz, John Tam, Roman A Melnyk
The Journal of Biological Chemistry|June 10, 2010
N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiationMia J Biondi, Greg L Beilhartz, Suzanne McCormick, et al.
Biochemical Pharmacology|April 15, 2017
Repurposing bacterial toxins for intracellular delivery of therapeutic proteinsGreg L Beilhartz, Seiji N Sugiman-Marangos, Roman A Melnyk
Science Translational Medicine|December 23, 2016
Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection"Greg L Beilhartz, John Tam, Zhifen Zhang, et al.
The Journal of Biological Chemistry|April 11, 2014
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociationGreg L Beilhartz, Marianne Ngure, Brian A Johns, et al.
Journal of Molecular Biology|March 18, 2009
HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibitionGreg L Beilhartz, Michaela Wendeler, Noel Baichoo, et al.
HIV Therapy|July 4, 2024
HIV ribonuclease H: continuing the search for small molecule antagonistsMichaela Wendeler, Greg L Beilhartz, John A Beutler, et al.
Chemistry & Biology|January 27, 2015
Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damageJohn Tam, Greg L Beilhartz, Anick Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B poreZhifen Zhang, Minyoung Park, John Tam, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Viruses|October 14, 2011
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and InhibitorsGreg L Beilhartz, Matthias Götte
Trends in Microbiology|November 9, 2015
Small Molecules Take A Big Step Against Clostridium difficileGreg L Beilhartz, John Tam, Roman A Melnyk
The Journal of Biological Chemistry|June 10, 2010
N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiationMia J Biondi, Greg L Beilhartz, Suzanne McCormick, et al.
Biochemical Pharmacology|April 15, 2017
Repurposing bacterial toxins for intracellular delivery of therapeutic proteinsGreg L Beilhartz, Seiji N Sugiman-Marangos, Roman A Melnyk
Science Translational Medicine|December 23, 2016
Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection"Greg L Beilhartz, John Tam, Zhifen Zhang, et al.
The Journal of Biological Chemistry|April 11, 2014
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociationGreg L Beilhartz, Marianne Ngure, Brian A Johns, et al.
Journal of Molecular Biology|March 18, 2009
HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibitionGreg L Beilhartz, Michaela Wendeler, Noel Baichoo, et al.
HIV Therapy|July 4, 2024
HIV ribonuclease H: continuing the search for small molecule antagonistsMichaela Wendeler, Greg L Beilhartz, John A Beutler, et al.
Chemistry & Biology|January 27, 2015
Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damageJohn Tam, Greg L Beilhartz, Anick Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B poreZhifen Zhang, Minyoung Park, John Tam, et al.
Pageof 3